norfenfluramine has been researched along with chlorpromazine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Brindley, DN; Sturton, RG | 2 |
3 other study(ies) available for norfenfluramine and chlorpromazine
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Factors controlling the activities of phosphatidate phosphohydrolase and phosphatidate cytidylyltransferase. The effects of chlorpromazine, demethylimipramine, cinchocaine, norfenfluramine, mepyramine and magnesium ions.
Topics: Animals; Chlorpromazine; Cytidine Diphosphate Diglycerides; Edetic Acid; Enzyme Activation; Glycerol-3-Phosphate O-Acyltransferase; Magnesium; Male; Microsomes, Liver; Norfenfluramine; Nucleotidyltransferases; Phosphatidic Acids; Phosphoric Monoester Hydrolases; Rats | 1977 |
Factors controlling the metabolism of phosphatidate by phosphohydrolase and phospholipase A-type activities. Effects of magnesium, calcium and amphiphilic cationic drugs.
Topics: Animals; Calcium; Cations; Chlorpromazine; In Vitro Techniques; Magnesium; Microsomes, Liver; Norfenfluramine; Phosphatidate Phosphatase; Phosphatidic Acids; Phospholipases; Phospholipases A; Phosphoric Monoester Hydrolases; Rats | 1980 |